retatrutide liver STUDY: Novel “Triagonist” Resolved Steatosis in Over 85% of Patients with MASLD and Obesity Retatrutide vs Tirzepatide (2026): Differences

Berberine has secondary evidence for metabolic support

Here's what oral GLP-1s offer: - Daily precision (adjust your dose day by day) - Greater flexibility in managing side effects - No needles required - Control over your treatment schedule The best treatment is the one that fits YOUR life and removes barriers to getting started

Surgical enhancements, such as facelifts and eyelid lifts, can last for many years, while fillers and other nonsurgical treatments require periodic maintenance

While drinking: guidelines Start with one drink

In Eli Lillys Phase 3 TRIUMPH-4 trial (December 2025), participants at the 12mg dose lost an average of 28.7% of body weight at 68 weeks up to 71.2 lbs per person